A recent report published by Infinium Global Research on translational regenerative medicine market provides in depth analysis of segments and sub-segments in global as well as regional translational regenerative medicine market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional translational regenerative medicine market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global translational regenerative medicine market. According to report the global translational regenerative medicine market is growing with a CAGR of 24.2 % from 2017 to 2023. Moreover, the global translational regenerative medicine market size was totaled 9.83 Billion in 2016 and it is estimated to reach USD 52.94 billion by the end of 2023.
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology. Regenerative medicines deal with the process of engineering & replacing human cells, tissues or organs to restore or establish normal function. Regenerative medicines primarily help to restore structure and function of damaged tissues and organs by stimulating body’s own repair mechanism. These medicines are used in wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications.
Figure 1: Global Translational Regenerative Medicine Market by Value 2015-2023
Rising awareness among people regarding regenerative medicines, increasing government initiative across the globe and growing aging population & healthcare expenditure are considered to be the key factors driving the growth of global translational regenerative medicine market. However, higher cost of research and development and complex government approval processes are major restraints for global regenerative medicine market. Increase in adoption of regenerative medicines and growth in aging population expected to bring new opportunities for growth over the forecast period.
North America is the largest market for regenerative medicines and accounted highest market shares as of 2015. High medical reimbursement facilities and technological advancement in the region are considered to be the key factors driving the dominance of North America in global regenerative medicines market.
The report on global translational regenerative medicine market covers segments such as, product type and application. On the basis of product type the global translational regenerative medicine market is categorized into tissue engineered products, cell based products and gene therapy products. On the basis of application the global translational regenerative medicine market is categorized into orthopedic, dermatology, cardiovascular, neurology, oncology, diabetes and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
Figure 2: Global Translational Regenerative Medicine Market by Region, CAGR % 2017-2023
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global translational regenerative medicine market such as, Anika Therapeutics, Nuvasive, Inc., Orthofix International N.V, MEDIPOST, Athersys, Inc., Celgene Corporation, Vericel Corporation, Novartis, Brainstorm Cell Therapeutics Inc. and Gamida Cell Ltd.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global translational regenerative medicine market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of translational regenerative medicine market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the translational regenerative medicine market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the translational regenerative medicine market to understand the present and future trends in this market and formulate their strategies accordingly.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter